Sysmex Corporation (TYO:6869)

Japan flag Japan · Delayed Price · Currency is JPY
2,801.00
-52.00 (-1.82%)
Mar 24, 2025, 1:41 PM JST
Market Cap 1.75T
Revenue (ttm) 501.85B
Net Income (ttm) 57.79B
Shares Out 623.58M
EPS (ttm) 92.65
PE Ratio 30.31
Forward PE 28.99
Dividend 30.00 (1.07%)
Ex-Dividend Date Mar 28, 2025
Volume 608,000
Average Volume 1,300,515
Open 2,850.00
Previous Close 2,853.00
Day's Range 2,796.00 - 2,852.50
52-Week Range 2,138.00 - 3,236.00
Beta 0.61
RSI 51.04
Earnings Date May 14, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;... [Read more]

Sector Healthcare
Founded 1968
Employees 10,042
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6869
Full Company Profile

Financial Performance

In 2023, Sysmex's revenue was 461.51 billion, an increase of 12.43% compared to the previous year's 410.50 billion. Earnings were 49.64 billion, an increase of 8.42%.

Financial Statements

News

Sysmex reports 9M results

5 weeks ago - Seeking Alpha

Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B

Sysmex (SSMXY) reports a strong 1H performance with GAAP EPS of ¥41.70 and revenue of ¥242.48B, an impressive 14.0% increase year-over-year.

4 months ago - Seeking Alpha